Literature DB >> 21658613

Host genetics in follicular lymphoma.

James R Cerhan1.   

Abstract

The role of inherited (host) genetic susceptibility in the pathogenesis of follicular lymphoma (FL) is reviewed. First degree relatives of FL patients are at an increased risk of FL, suggesting a role for inherited factors. While there have been no linkage studies in FL families, candidate gene and genome-wide association studies have identified several risk loci which have been confirmed in independent studies. These include regions on 6p21.32-33 and TNF family members. Host genetics has also been hypothesized to influence treatment response, disease progression and overall survival. Early leads in FL prognosis include pathways that regulate immune function, antibody-dependent cellular cytotoxicity, chemotaxis, and one-carbon metabolism, although few of these associations have been independently confirmed. While the use of host genetics to identify individuals at high risk of FL or to predict FL treatment response and prognosis appears to be very promising, it is not yet ready for the clinic.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21658613      PMCID: PMC3112359          DOI: 10.1016/j.beha.2011.02.004

Source DB:  PubMed          Journal:  Best Pract Res Clin Haematol        ISSN: 1521-6926            Impact factor:   3.020


  98 in total

1.  The International HapMap Project.

Authors: 
Journal:  Nature       Date:  2003-12-18       Impact factor: 49.962

2.  Familial cancers associated with subtypes of leukemia and non-Hodgkin's lymphoma.

Authors:  L M Pottern; M Linet; A Blair; F Dick; L F Burmeister; R Gibson; L M Schuman; J F Fraumeni
Journal:  Leuk Res       Date:  1991       Impact factor: 3.156

Review 3.  The role of the BAFF/APRIL system in B cell homeostasis and lymphoid cancers.

Authors:  Fabienne Mackay; Stuart G Tangye
Journal:  Curr Opin Pharmacol       Date:  2004-08       Impact factor: 5.547

4.  Familial aggregation of Hodgkin lymphoma and related tumors.

Authors:  Lynn R Goldin; Ruth M Pfeiffer; Gloria Gridley; Mitchell H Gail; Xinjun Li; Lene Mellemkjaer; Jørgen H Olsen; Kari Hemminki; Martha S Linet
Journal:  Cancer       Date:  2004-05-01       Impact factor: 6.860

5.  Polymorphisms and haplotypes in folate-metabolizing genes and risk of non-Hodgkin lymphoma.

Authors:  Christine F Skibola; Matthew S Forrest; Fabio Coppedé; Luz Agana; Alan Hubbard; Martyn T Smith; Paige M Bracci; Elizabeth A Holly
Journal:  Blood       Date:  2004-06-15       Impact factor: 22.113

6.  Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands.

Authors:  D E Goldgar; D F Easton; L A Cannon-Albright; M H Skolnick
Journal:  J Natl Cancer Inst       Date:  1994-11-02       Impact factor: 13.506

Review 7.  Familial (inherited) leukemia, lymphoma, and myeloma: an overview.

Authors:  George B Segel; Marshall A Lichtman
Journal:  Blood Cells Mol Dis       Date:  2004 Jan-Feb       Impact factor: 3.039

8.  Follicular lymphoma international prognostic index.

Authors:  Philippe Solal-Céligny; Pascal Roy; Philippe Colombat; Josephine White; Jim O Armitage; Reyes Arranz-Saez; Wing Y Au; Monica Bellei; Pauline Brice; Dolores Caballero; Bertrand Coiffier; Eulogio Conde-Garcia; Chantal Doyen; Massimo Federico; Richard I Fisher; Javier F Garcia-Conde; Cesare Guglielmi; Anton Hagenbeek; Corinne Haïoun; Michael LeBlanc; Andrew T Lister; Armando Lopez-Guillermo; Peter McLaughlin; Noël Milpied; Pierre Morel; Nicolas Mounier; Stephen J Proctor; Ama Rohatiner; Paul Smith; Pierre Soubeyran; Hervé Tilly; Umberto Vitolo; Pier-Luigi Zinzani; Emanuele Zucca; Emili Montserrat
Journal:  Blood       Date:  2004-05-04       Impact factor: 22.113

9.  Familial risk of lymphoproliferative tumors in families of patients with chronic lymphocytic leukemia: results from the Swedish Family-Cancer Database.

Authors:  Lynn R Goldin; Ruth M Pfeiffer; Xinjun Li; Kari Hemminki
Journal:  Blood       Date:  2004-05-25       Impact factor: 22.113

10.  Body mass index, leptin and leptin receptor polymorphisms, and non-hodgkin lymphoma.

Authors:  Christine F Skibola; Elizabeth A Holly; Matthew S Forrest; Alan Hubbard; Paige M Bracci; Danica R Skibola; Christine Hegedus; Martyn T Smith
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2004-05       Impact factor: 4.254

View more
  3 in total

Review 1.  Familial predisposition and genetic risk factors for lymphoma.

Authors:  James R Cerhan; Susan L Slager
Journal:  Blood       Date:  2015-09-24       Impact factor: 22.113

Review 2.  Epidemiology of Follicular Lymphoma.

Authors:  James R Cerhan
Journal:  Hematol Oncol Clin North Am       Date:  2020-05-05       Impact factor: 3.722

3.  Follicular lymphoma-protective HLA class II variants correlate with increased HLA-DQB1 protein expression.

Authors:  F C M Sillé; L Conde; J Zhang; N K Akers; S Sanchez; J Maltbaek; J E Riby; M T Smith; C F Skibola
Journal:  Genes Immun       Date:  2013-12-05       Impact factor: 2.676

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.